CureVac N.V. (CVAC) has a market capitalization of $1.05B and trades at $4.66. The 52-week range is 2.475-5.72.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 6.5, Earnings Per Share (EPS) of $0.72, annual revenue of $535.18M.
The stock has a beta of 1.84, operates in the Healthcare sector.
